How do you manage TTFields for a patient with glioblastoma in the setting of disease progression?

Continuation of Tumor Treating Field (TTF) therapy at progression is an individualized decision for each patient.

In the EF-14 trial upon which TTF was approved for newly diagnosed GBM after chemoradiotherapy, TTF was able to be continued until second progression. In this study, 18% more patients wer...